Spectral AI, Inc.

Equities

MDAI

US84757T1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 08/06/2024 am IST			5-day change	1st Jan Change
1.55 ^USD	-1.90%		-6.63%	-36.99%

06/06	Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study	CI
16/05	Spectral AI, Inc. Appoints Erich Spangenberg as A Director	CI

Spectral AI, Inc. Provides Revenue Guidance for the Fiscal Year 2023 and 2024

November 14, 2023 at 04:41 am IST

Spectral AI, Inc. provided revenue guidance for the fiscal year 2023 and 2024. for the year 2023, the company expects revenue of approximately $17.4 million.

For the year 2024, the company expects revenue of approximately $28.0 million.

Latest news about Spectral AI, Inc.

Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study	06/06	CI
Spectral AI, Inc. Appoints Erich Spangenberg as A Director	17/05	CI
Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Transcript : Spectral AI, Inc., Q1 2024 Earnings Call, May 07, 2024	08/05
Spectral AI, Inc. Reiterates Revenue Guidance for the Year 2024	08/05	CI
Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary	24/04	CI
Spectral AI, Inc. Announces Chief Operating Office Changes	03/04	CI
Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer	01/04	CI
Spectral AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
Spectral AI, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03	CI
Transcript : Spectral AI, Inc., Q4 2023 Earnings Call, Mar 27, 2024	28/03
Spectral AI, Inc. announced that it expects to receive $30 million in funding	20/03	CI
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of Deepview? Wound Imaging System	12/03	CI
Spectral AI, Inc. Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem	07/03	CI
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	01/03	MT
Spectral AI, Inc. Announces Chief Executive Officer Changes	01/03	CI
Spectral AI, Inc. Announces Management Changes	01/03	CI
Spectral AI, Inc. Appoints Vincent S. Capone as Chief Financial Officer	01/03	CI
Spectral AI, Inc. Re-Affirms Revenue Guidance for the Full Year 2024	01/03	CI
Spectral AI, Inc. Receives UKCA Authorization for Burn Indication Expected Commercialization Second Half 2024	22/02	CI
Spectral AI, Inc. Announces Board Changes	12/02	CI
Spectral AI Expects Positive Results From Predictive Diagnostic Device -- Shares Decline	06/02	MT
Spectral AI, Inc. Announces Resignation of Michael Murphy as Director	02/02	CI
Top Premarket Gainers	29/01	MT
BTIG Initiates Spectral AI at Buy Rating With $4 Price Target	23/01	MT

Chart Spectral AI, Inc.

Duration

Period

More charts

Company Profile

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Sector

Advanced Medical Equipment & Technology

Calendar

25/06/2024 - Northland Growth Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Spectral AI, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.55 USD

Average target price

5.867 USD

Spread / Average Target

+278.49%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
SPECTRAL AI, INC.	-36.99%	27.1M
VEEVA SYSTEMS INC.	-4.87%	29.6B
PRO MEDICUS LIMITED	+31.35%	8.65B
SECTRA AB	+34.03%	4.42B
EVOLENT HEALTH, INC.	-28.91%	2.69B
VERADIGM INC.	-9.91%	1.6B
OMNICELL, INC.	-21.02%	1.36B
LUNIT INC.	-35.78%	1.1B
SIMULATIONS PLUS, INC.	+3.28%	924M
B-SOFT CO.,LTD.	-43.36%	791M

Medical Software & Technology Services